In Kerala's tropical, humid climate with high UV exposure, concurrent use of broad-spectrum SPF 50+ UVA/UVB sunscreen is mandatory to prevent photodamage and mitigate PIH risk
10 Slowing of gastric emptying, primarily within the first hour post meal, has been demonstrated with short-term liraglutide treatment at doses up to 1.8 mg in T2DM, 11, 12 although no dose response between liraglutide 1.2 and 1.8 mg was observed
( )
Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]